Sign inJoin waitlistJoin the waitlist

Emmanuel Walter

Pediatrics

Credentials: · · ·

History

Pediatrics
Duke University Hospital
1987–1990
Pediatrics
University of Maryland School of Medicine
1983–1987
University of Maryland School of Medicine
1979–1983

Research

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
New England Journal of Medicine · 2021 · 698 citations
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
New England Journal of Medicine · 2022 · First of 35 authors · 477 citations
Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial
JAMA · 2014 · 403 citations

Patricia Winokur
25 papers
Sharon Frey
23 papers
NR
Nadine Rouphael
20 papers
Geeta Swamy
19 papers · 5 as a resident
KB
Karen Broder
19 papers
Dennis Clements
18 papers
Michael Moody
17 papers · 3 as a resident
RA
Robert Atmar
17 papers
Clarence Creech
16 papers
Kathryn Edwards
15 papers
LJ
Lisa Jackson
15 papers
Mary Staat
13 papers

Grants

The Duke Catalyzing Observations into Mechanistic Models of Influenza Transmission (COMMIT) Center
National Institute of Allergy and Infectious Diseases · P01
Project lead · $333.4K · Duke University
2026–2031
RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings
NCIRD · U01
Contact PI · $3.5M · Duke University
2022–2027
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)
NIH Office of the Director · N01
Contact PI · $24.1M · Seattle Children's Hospital
2019–2026
Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
NIH Office of the Director · N01
Contact PI · $20.6M · University of Alabama at Birmingham
2013–2023

Clinical trials

Immunogenicity of Influenza Vaccinations
Principal investigator · Completed · Phase 4
Duke University
2024–2025
Trial of an Inactivated Yellow Fever Virus Vaccine
Principal investigator · Completed · Phase 1
Najit Technologies, Inc.
2022–2023
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
Principal investigator · Completed · Phase 4
Duke University
2021–2023
Increasing Vaccine Uptake Among Adolescents in the Rural South
Principal investigator · Completed
Duke University
2021–2022